France· FR:68773605
EMCITATE 350 microgrammes, comprimé dispersible
A medicinal product containing tiratricol, registered in France by RARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TIRATRICOL
- Manufacturer
- RARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400930310700plaquette(s) PVC aluminium de 60 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tiratricol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEmcitate 350 µgRare Thyroid Therapeutics International
- CzechiaEMCITATERare Thyroid Therapeutics International AB, Stockholm
- SpainEMCITATE 350 MICROGRAMOS COMPRIMIDOS DISPERSABLESRare Thyroid Therapeutics International Ab
- FinlandEmcitateRare Thyroid Therapeutics International AB
- United KingdomTeatrois 0.35mg tabletsImported (France)
- IrelandEmcitate 350 microgram dispersible tabletsRare Thyroid Therapeutics International AB
- IcelandEmcitateRare Thyroid Therapeutics International AB
- NetherlandsEmcitate 350 microgram dispergeerbare tablettenRare Thyroid Therapeutics International AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Emcitate
- Liechtenstein · Emcitate
- Norway · Emcitate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe19a030-1599-4156-8e3a-e264403e3aec GET /v1/drugs/fe19a030-1599-4156-8e3a-e264403e3aec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68773605",
"date_amm": "2025-02-12",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/24/1897",
"substance": "TIRATRICOL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé dispersible",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tiratricol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.